coumarin has been researched along with selegiline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Matos, MJ; Santana, L; Uriarte, E; Vazquez-Rodriguez, S; Viña, D | 1 |
Fontenla, JA; Friedman, C; Gonzalez-Franco, RM; Matos, MJ; Santana, L; Tatonetti, NP; Uriarte, E; Vilar, S; Viña, D | 1 |
4 other study(ies) available for coumarin and selegiline
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Topics: Coumarins; Humans; Iproniazid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 2011 |
Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
Topics: Animals; Biocatalysis; Carbamates; Coumarins; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Mice; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Protein Binding; Protein Structure, Tertiary; Selegiline; Substrate Specificity; Tyramine | 2013 |